EXHIBIT 32.1


                    STATEMENT PURSUANT TO 18 U.S.C. ss.1350


   Pursuant to 18 U.S.C. ss.1350, the undersigned certifies that this Quarterly
Report on Form 10-Q for the period ended June 30, 2004 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and that the information contained in this report fairly presents, in all
material respects, the financial condition and results of operations of
Savient Pharmaceuticals, Inc.

February 22, 2005

                                   /s/ Christopher Clement
                                   -------------------------------------
                                   Christopher Clement
                                   President and Chief Executive Officer


                                       46